Vaccine Sector Rally Over for These 2 Stocks

Both stocks are still eyeing impressive year-to-date wins, however

Digital Content Manager
Dec 29, 2021 at 9:36 AM
facebook twitter linkedin

Vaccine stocks have been in a recent downfall, and getting hit particularly hard are Moderna Inc (NASDAQ:MRNA) and BioNTech SE (NASDAQ:BNTX). At last check, MRNA was down 1.3% to trade at $238.36, while BioNTech stock was last seen down 3% at $234.20. 

Both stocks are extending lengthy losing streaks. Starting with BNTX, the security is pacing for its seventh-daily drop, marking its longest slump since late August. The recent drop has put the stock back below long-term support at its 200-day moving average, though the shares look ready to ring in the new year with an over 196% lead for 2021. 

Moderna stock hasn't fared much better, as its also headed for its seventh-straight loss, which would be its longest daily lose streak since June 2019. Similarly to BNTX, MRNA still sports an impressive year-to-date lead of 131%, though today's dip could put the stock south of recent support at the $240 area. 

Analysts seem to have predicted this selloff, as the brokerage bunch has been hesitant on both stocks. Currently, all but one of the seven covering BNTX call it a "hold." Meanwhile, Moderna stock has enjoyed a slightly better reception, with five "strong buy" ratings to its name, however, the eight others in coverage consider it a "hold" or worse. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners